1Cademy - Results of the Efficacy of Hydroxychloroquine in Patients with COVID-19 Study

Concept

Results of the Efficacy of Hydroxychloroquine in Patients with COVID-19 Study

The average control group recovery time from having a fever on the initial day of treatment was 1.3 days
The average experimental group recovery time from having a fever on the initial day of treatment was 0.4 days
In patients who had a cough on the initial day of treatment in both clinical trial groups, the use of HCQ in the experimental group was seen to significantly shorten the duration of this symptom in patients
All 4 patients who eventually developed severe COVID were in the control group
Only 2 patients developed mild reactions to HCQ
Based on chest CT scans, pneumonia improved in 67.7% of all patients in this clinical trial
All data reported were statistically significant (p < 0.05)
80.6% of patients in the experimental group had improved pneumonia vs 54.8% in the control group
61.3% of patients in the HCQ treatment group had significantly improved pneumonia

0

1

Updated 2020-08-13

Contributors are:

Who are from:

References